Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

Report Code: BIO113D

Publish Date: Jul 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global nanoparticles in biotechnology, drug development, and drug delivery systems market should reach $156.8 billion by 2028 from $102.7 billion in 2023 at a compound annual growth rate (CAGR) of 8.8% for the forecast period of 2023 to 2028.

Report Includes

  • 25 data tables and 40 additional tables
  • An updated overview and in-depth analysis of the global markets for nanoparticles in biotechnology, drug development and drug delivery systems
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimation of the actual market size and revenue forecast for nanoparticles in biotechnology, drug development and drug delivery systems market, and corresponding market share analysis by technology, application and region
  • Highlights of the drug development, formulation, and the development of new drug delivery systems and detailed product analyses within health and wellness subsegments
  • In-depth information (facts and figures) concerning the major factors influencing the progress of the market (benefits and industry-specific challenges) with respect to specific growth trends, upcoming technologies, prospects, and contributions to the overall market
  • Discussion on the role of nanotechnology in the COVID-19 vaccine production, mechanism of action, components and methods in vaccine design for COVID-19 and challenges for vaccine disruptions
  • Review of the leading and emerging drug products for each nanoparticle type, clinical trial landscape for various candidate nanodrugs, status of approvals of drugs in each segment, and penetration of technologies and research initiatives within the ecosystem
  • Updated information on patents and patent applications on nanoparticles in biotechnology, drug development and drug delivery systems, and related scientific publications
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performances, and segmental revenues
  • Descriptive company profiles of the leading global players in the market, including Bristol-Myers Squibb Co., Camurus, GlaxoSmithKline PLC, Merck & Co. Inc. and Novartis AG

Report Scope

The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and formulation, drug delivery systems, and diagnostics as well as analyses of global market trends, using 2022 as the base year and forecasting market sizes for 2023 through 2028 with compound annual growth rate (CAGR) projections.

The report includes an analysis of leading and emerging drug products for each nanoparticle type. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products will alter the quality of life of patients receiving nanoparticle-associated drugs.

Market figures are based on revenues at the manufacturer level and are projected in dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, new product introductions, expanded markets for existing products, and other factors affecting the market.

The study is arranged to offer an overview of existing nanoparticle technology and drug markets; it is accompanied by nanoproduct, company, geography, and mechanism of action, with forecasts broken down and covered by geographic regions and countries. Patent and clinical trial information is reviewed for various candidate nanodrugs. The status of approvals of drugs in each segment by the FDA and regulatory agencies in other countries is reviewed.

Figures are reported in U.S. dollars and each case reflects currency fluctuations within the performance of revenue change. Revenue figures do not account for variations in local currencies. All market share data presented is on a global basis unless specifically mentioned.

Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, and the Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $95.3 billion
Market size forecast $156.8 billion
Growth rate CAGR of 8.8%
Units considered $ Billions
Segments covered By technology, application, and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Countries covered U.S., Mexico, Canada, Germany, France, U.K., Italy, Spain, Rest of Europe, China, India, Japan, Rest of Asia-Pacific, South America, Middle East and Africa
Key Market Drivers
  • Growing Research and Development Activities in the Nanoparticles Industry
  • Government Funding Support for Nanotechnology
  • Increasing Prevalence of Cancer and the Need for Effective Cancer Treatment
Companies studied
BRISTOL-MYERS SQUIBB CO.CAMURUS AB
CERAMISPHERE PTY LTD.CYTIMMUNE SCIENCES
GILEAD SCIENCES INC.GSK PLC.
F. HOFFMANN-LA ROCHE LTD.MERCK & CO. INC.
NANOCARRIER CO. LTD.NOVARTIS AG
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global market for nanoparticles in biotechnology, drug development, and drug delivery systems is estimated at $102.7 billion in 2023 and is expected to grow at a CAGR of 8.8% to $156.8 billion by 2028.
The nanoparticles in biotechnology, drug development, and drug delivery systems market growth is majorly driven by the increased demand for targeted drug delivery systems, and use of nanoparticles in diagnostic imaging. Diagnostic nanoparticles seek to both visualize illnesses and advance knowledge of crucial (patho-) physiological concepts underlying various diseases and disease therapies. The development of nanoparticles and their rapid incorporation into the research and development has also given rise to a new area of application in biotechnology and diagnostics involving particle materials in the nanometer size range.
The nanoparticles in biotechnology, drug development, and drug delivery systems market is segmented based on technology, application, region, and countries.
Drug delivery systems segment will dominate the market by the end of 2027.
North America holds the highest share in the market.
Key companies in the market includes Camurus AB, Merck & Co. Inc, GlaxoSmithKline PLC, NanoCarrier Co., Ltd., Cytimmune Science, Inc., and Novartis AG among others.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems174Free
Chapter- 1: Introduction9Free
Chapter- 2: Summary and Highlights6Free
Chapter- 3: Market Overview21Free
Chapter- 4: Role of Nanotechnology in COVID-19 Vaccine Production5Free
Chapter- 5: Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Technology 6Free
Chapter- 6: Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Application 5Free
Chapter- 7: Structure of Nanoparticles6Free
Chapter- 8: Production of Nanoparticles7Free
Chapter- 9: Nanoparticles in Biotechnology8Free
Chapter- 10: Nanoparticles in Drug Development and Formulation8Free
Chapter- 11: Nanoparticles in Drug Delivery Systems33Free
Chapter- 12: In Vitro and In Vivo Diagnostic Imaging3Free
Chapter- 13: Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems by Region11Free
Chapter- 14: Competitive Landscape15Free
Chapter- 15: Patents, Licensing, Mergers and Acquisitions3Free
Chapter- 16: Company Profiles28Free
Published - Jan-2021| Analyst - BCC Publishing| Code - BIO113C

Report Highlights

The global market for nanoparticles in biotechnology, drug development and drug delivery should grow from $83.4 billion in 2020 to $123.6 billion by 2025, at a compound annual growth rate (CAGR) of 8.2% for the period of 2020-2025.

Report Includes

  • 43 tables
  • An overview of the global nanoparticles in biotechnology, drug development and drug delivery market
  • Estimation of the market size and analyses of market trends, with data from 2019, estimates for 2020 and projection of CAGR through 2025
  • Highlights of the drug development, formulation, and the development of new drug delivery systems and detailed product analyses within health and wellness subsegments
  • Information on nanomedicine and biomedical nanoparticle products and coverage of the next generation vaccines
  • Evaluation of current market trends, market size, market forecast, and detailed analysis of drivers, challenges, and opportunities affecting market growth
  • Discussion on the role of nanotechnology in COVID-19 vaccine production, components, and methods in the vaccine design for COVID-19 and challenges for vaccine disruptions
  • Assessment of various approaches for the treatment of COVID-19, and detailed description of structure and penetration of corona virus
  • Details of clinical trials of nanoparticle drugs and drug delivery systems
  • A look at the patents, licensing, mergers and acquisitions and market share analysis of the key companies of the industry
  • Company profiles of major players including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Hofmann-La Roche Inc., Merck & Co., and Novartis AG
Published - Aug-2014| Analyst - Jackson Highsmith| Code - BIO113B

Report Highlights

The global market for nanoparticles in biotechnology and pharmaceuticals reached nearly $25.0 billion in 2013. This market is expected to reach $29.6 billion in 2014 and $79.8 billion in 2019, with a compound annual growth rate (CAGR) of 22.0% for the period of 2014 to 2019.

Report Includes

  • An overview of the global market for nanoparticles in biotechnology, drug development, and drug delivery.
  • Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
  • A review of existing drug products and potential drugs in the pipelines of the major pharmaceutical players in the market.
  • A look at how market growth is being driven in emerging geographies stemming from the health awareness of the growing middle class in countries such as India, China, Brazil and Russia.
  • Analysis of changing market dynamics, emerging players and products, strategies for accessing emerging markets, and analysis of specific disease prevalence.
  • Profiles of manufacturers of leading products and information on their specific products.
Published - Sep-2012| Analyst - Jackson Highsmith| Code - BIO113A

Report Highlights

The global market for nanoparticles in biotechnology, drug development and drug delivery was valued at $17.5 billion in 2011 and should reach nearly $21.6 billion in 2012. Total market value is expected to reach $53.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 19.9%.

Related Reports

Breakthrough Therapies: Market Dynamics and Investment Opportunities

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM176B

The global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.

Drug Discovery Technologies

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

Global Markets and Technologies for Carbon Nanotubes

Published - Aug 2024 | Publisher - BCC Publishing | Code - NAN024G

The global market for carbon nanotubes was valued at $2.0 billion in 2023. The market is projected to grow from $2.3 billion in 2024 to $5.9 billion by 2029, at a compound annual growth rate (CAGR) of 20.6% from 2024 through 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Recent Reports

Global DNA Sequencing: Research, Applied and Clinical Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - BIO045J

The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.

Artificial Intelligence (AI) in Cancer

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO196B

The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Induced Pluripotent Stem Cells: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO135F

The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems
Sample Report